128
Participants
Start Date
May 2, 2022
Primary Completion Date
August 31, 2024
Study Completion Date
December 31, 2024
Psilocybin
Psilocybin and psychotherapy
Placebo
Placebo and psychotherapy
A-Klinikka, Kouvola
Sabi Mind, Calgary
Okanagan Clinical Trials, Kelowna
Centre for Neurology Studies, Surrey
Department of Psychiatry, Queen's University, Kingston
Research Center Oxidi Oy / Addiktum Oy, Helsinki
Mentacare Oy, Oulu
Addiktum Oy, Turku
University of British Columbia, Department of Psychiatry, BRAIN Lab, Vancouver
Centricity Research, Halifax
MacAnxiety Research Centre, Hamilton
Centre for Addiction and Mental Health, Toronto
Lead Sponsor
Collaborators (1)
Clairvoyant Therapeutics
INDUSTRY
Optimapharm
INDUSTRY